Custom Search
Etodolac News
NICE launches guidance on COX-2 selective inhibitors
The cyclo-oxygenase-2 (COX-2) selective inhibitors celecoxib (Celebrex), etodolac (Lodine SR), rofecoxib (Vioxx) and meloxicam (Mobic) should only be used to treat patients with rheumatoid arthritis or osteoarthritis who are at...
Displaying results 6 to 6 out of 6